FDA Investigator Jose Ohernandez Guzman
Jose Ohernandez Guzman has inspections in 2 countries as of 27 Jul 2023. Jose Ohernandez Guzman has collaborated with a combined 1153 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
27 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Israel,
United States of America
Co-Investigator(s):
Aditi S Thakur,
Alberto A Viciedo,
Alice S Tsao,
Bo Chi, PhD,
Bruce G Cooper,
Cameron J Smith,
Carlos Chavez,
Charisse K Green,
Charles Yuanchia Kuo, PhD,
Danna E Solorzano,
Dawn L Wydner,
Demitria J Xiradakis,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Frank Verni,
Guerlain Ulysse,
Jacobson,
James A Liubicich,
Jay T Wong,
Jose O Hernandez,
Juandria V Williams,
Julie Scoma,
Kathleen M Jordan,
Kevin J Flessa,
Kimberly Y Smithson,
Ko U Min,
Leiyun Boone, PhD,
Marion Michaelis,
Mark R Mcclain,
Marlene G Swider,
Megan A Haggerty,
Michael A Charles,
Michael R Klapal,
Nailing Zhang,
Nealie C Newberger,
Nicholas C Mendiola,
Patricia Fhughes Troost,
Paul L Bellamy,
Paul Mouris,
Peter Abel,
Prabhu P Raju,
Rachael A Moliver,
Ramon E Martinez,
Russ E Davis,
Russell J Glapion,
Saied A Asbagh,
Saleem A Akhtar,
Samina S Khan,
Samuel Mindaye,
Sharon K Pederson,
Sharon K Thoma, PharmD,
Smith,
Sony Mathews,
State Agency,
Steven J Libal,
Tamil Arasu, PhD,
Thomas J Mooney,
Thuy T Nguyen, LCDR,
Uduak M Inokon,
Wayne E Seifert,
Wendy G Tan, PhD,
Wendy Tam,
William J Leonard,
William P Chilton,
Yan Wang,
Yvesna C Blaise,
Zedong Dong,
Zhihao Qiu (Peter), PhD
Jose Ohernandez Guzman's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2016 | FDA 483 | Natrium Products, Inc. - Form 483, 2016-06-30 |
January, 2016 | FDA 483 | Topiderm, Inc. - Form 483, 2016-01-21 |
December, 2015 | FDA 483 | Advance Pharmaceutical, Inc. - Form 483, 2015-12-02 |
March, 2018 | FDA 483 Response | ImClone Systems LLC - Form 483R, 2018-03-27 |
June, 2019 | FDA 483 | Infusion Options Inc. - Form 483, 2019-06-25 |
July, 2017 | EIR | Alexion Pharmaceuticals, Inc. - EIR, 2017-07-21 |
November, 2017 | FDA 483 | Rafa Laboratories Ltd. - Form 483, 2017-11-13 |
July, 2017 | FDA 483 | Alexion Pharmaceuticals, Inc. - Form 483, 2017-07-21 |
March, 2018 | FDA 483 | ImClone Systems LLC - Form 483, 2018-03-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more